New vaccine shows potential in preventing recurrence of triple-negative breast cancer
DNA
Washington University School of Medicine Nov 14 2024 A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine -; known as a neoantigen DNA vaccine -; for breast cancer patients. The study,
din zilele anterioare